首页> 外文期刊>Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts >Antibacterial use in community practice: assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance.
【24h】

Antibacterial use in community practice: assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance.

机译:社区实践中的抗菌药物使用:评估数量,适应症和适当性,以及与抗菌素耐药性发展的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Most use of antibacterials occurs in community practice; however, despite the widespread belief of inappropriate use and the resultant increase in antibacterial resistance, little data exist describing antibacterial use in this setting. A MEDLINE search of English-language articles was conducted for epidemiological studies assessing quantity, indication and appropriateness of antibacterial use in community practice. A 1983 study of international antibacterial use described considerable disparities in quantity of use between countries. Subsequent longitudinal studies from the US, Canada, Australia and the UK described changing patterns of antibacterial use. No increase in the total rate of antibacterial use was reported by any of the 4 countries; however, all countries reported increased use of newer and/or broad-spectrum agents (e.g. fluoroquinolones, amoxicillin-clavulanic acid, cephalosporins and new macrolides] coupled with decreased use of older and/or narrow-spectrum agents [e.g. phenoxymethylpenicillin (penicillin V), erythromycin, ampicillin and tetracycline). Most (approximately three-quarters) use of antibacterials was in the treatment of respiratory tract infections. Prescribing rates for respiratory tract infections of presumed viral aetiology (e.g. the common cold) ranged from 17 to 60% in the UK and US, respectively. Among indications for which antibacterials were indicated, the appropriateness of antibacterial use received little study. Correspondingly, the rates of antibacterial resistance among common respiratory pathogens (Streptococcus pneumoniae and Haemophilus influenzae) have increased significantly in the past decade, although disparities exist between countries. Antibacterial use is considered a major factor in the development of antibacterial resistance, although the relationship between community antibacterial use and resistance has been poorly described. Further study of antibacterial usage patterns and associated resistance patterns is fundamental to the development of methods to reduce unnecessary and inappropriate use, thereby slowing the development of antibacterial resistance in the community.
机译:抗菌剂的大多数使用发生在社区实践中。然而,尽管人们普遍认为使用不当会导致抗菌素耐药性的增加,但很少有数据描述这种情况下的抗菌素使用。进行了MEDLINE英文文章搜索,以进行流行病学研究,以评估社区实践中使用抗菌药物的数量,适应症和适当性。 1983年的一项国际抗菌药物使用研究表明,各国之间的使用量存在很大差异。随后来自美国,加拿大,澳大利亚和英国的纵向研究描述了抗菌药物使用方式的变化。 4个国家中没有任何一个国家报告总的抗菌药物使用率增加。然而,所有国家都报告增加了对新药和/或广谱药物(如氟喹诺酮类药物,阿莫西林-克拉维酸,头孢菌素和新大环内酯类药物)的使用,同时减少了对旧和/或窄谱药物(如苯氧甲基青霉素(青霉素V))的使用,红霉素,氨苄青霉素和四环素)。大多数(大约四分之三)抗菌药物用于治疗呼吸道感染。在英国和美国,假定的病毒性病因(例如普通感冒)呼吸道感染的开处方率分别为17%至60%。在指出需要使用抗菌药物的适应症中,很少使用抗菌药物。相应地,尽管国家之间存在差异,但在过去的十年中,常见的呼吸道病原体(肺炎链球菌和流感嗜血杆菌)的抗菌素耐药率已大大提高。抗菌药物的使用被认为是产生抗菌药物耐药性的主要因素,尽管社区抗菌药物使用与耐药菌之间的关系很少被描述。进一步研究抗菌药物使用模式和相关耐药模式是开发减少不必要和不适当使用方法的基础,从而减缓了社区中抗菌药物耐药性的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号